QCM
WST icon

QRG Capital Management’s West Pharmaceutical WST Stock Holding History

QRG Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$702K Buy
1,954
+274
+16% +$83.8K 0.01% 750
2026
Q1 		$421K Sell
1,680
-640
-28% -$159K ﹤0.01% 838
2025
Q4 		$638K Buy
2,320
+587
+34% +$161K 0.01% 689
2025
Q3 		$455K Buy
1,733
+370
+27% +$89.9K 0.01% 755
2025
Q2 		$298K Sell
1,363
-10
-0.7% -$2.14K ﹤0.01% 967
2025
Q1 		$307K Sell
1,373
-498
-27% -$137K ﹤0.01% 907
2024
Q4 		$613K Buy
1,871
+369
+25% +$116K 0.01% 714
2024
Q3 		$451K Sell
1,502
-8
-0.5% -$2.45K ﹤0.01% 806
2024
Q2 		$497K Sell
1,510
-357
-19% -$126K 0.01% 734
2024
Q1 		$739K Sell
1,867
-2,421
-56% -$896K 0.01% 632
2023
Q4 		$1.51M Buy
4,288
+354
+9% +$125K 0.02% 457
2023
Q3 		$1.48M Buy
+3,934
New +$1.52M 0.03% 421

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

QRG Capital Management's WST Position: Q2 2026 in Review

QRG Capital Management increased its West Pharmaceutical (WST) stake by 16% in Q2 2026, buying an estimated $83.8K and bringing the position to 1,954 shares worth $702K. The position accounts for 0.01% of the portfolio, ranked #750.

QRG Capital Management first reported a position in WST in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.51M in Q4 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • QRG Capital Management held 1,954 shares of West Pharmaceutical worth $702K as of Q2 2026.
  • QRG Capital Management bought 274 West Pharmaceutical shares in Q2 2026, an estimated $83.8K.
  • West Pharmaceutical made up 0.01% of QRG Capital Management's portfolio in Q2 2026, its #750 holding.
  • QRG Capital Management first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's West Pharmaceutical position peaked at $1.51M in Q4 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.